SCHEMBL7674833

SCHEMBL7674833

COC(=O)c1cccc(S(=O)(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.43
CASR P41180 1/20 0.42
SLC40A1 Q9NP59 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
LOX P28300 1/20 0.40
BRD4 O60885 1/20 0.40
TDP1 Q9NUW8 3/20 0.40
STAT3 P40763 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KMT2A Q03164 1/20 0.39
F2 P00734 1/20 0.39
TMPRSS6 Q8IU80 1/20 0.39
SDHB P21912 1/20 0.39
TCF4 P15884 2/20 0.39
CTNNB1 P35222 2/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691554 0.90 CYP2C19 (0.45) ACLYCA1CA2KDM4EKMT2A
SCHEMBL7671455 0.89 ACLY (0.41) ACLYCASRSLC40A1CA12CA1
SCHEMBL7673646 0.86 SMN1; SMN2 (0.43) CA12CA1CA2CA9ALDH1A1
SCHEMBL7671552 0.80 STAT3 (0.52) STAT3F2TMPRSS6PLAU
SCHEMBL15753531 0.80 HDAC8 (0.51) ACLYCASRSLC40A1TDP1STAT3
SCHEMBL7685704 0.80 CYP2C19 (0.44) ACLYCA1CA2TDP1F2
SCHEMBL7667753 0.79 F2 (0.52) ACLYSLC40A1LOXBRD4TDP1
SCHEMBL7692231 0.78 TDP1 (0.49) TDP1ALDH1A1KMT2AF2L3MBTL1
SCHEMBL782653 0.77 F2 (0.53) ACLYSLC40A1ALDH1A1F2TMPRSS6
SCHEMBL7669327 0.77 MMP9 (0.57) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed